Recurrent bladder carcinoma
In 2011 - 2013 the Dept. Urology of VU University Medical Center, Amsterdam, the Netherlands organizes a multicenter phase II study for local IL-2 therapy, more info in Dutch.
The study will also be performed at the Academic Medical Center and the Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
For more information email to Dr J.J.L. Jacobs, blaaskanker2011@gmail.com
The study will also be performed at the Academic Medical Center and the Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
For more information email to Dr J.J.L. Jacobs, blaaskanker2011@gmail.com
References
Tubaro et al. (1995) Eur. Urol. 28, 297
W. Den Otter et al. (1998) J. Urol. 159, 1183
Grasso et al. (2001) J. Immunother. 24, 184
JJL Jacobs et al. The Open Cancer Immunology Journal 3 : 8-14 (2010).D. Characiejus et al. Anticancer Research 31:699-703(2011).
W. Den Otter et al. (1998) J. Urol. 159, 1183
Grasso et al. (2001) J. Immunother. 24, 184
JJL Jacobs et al. The Open Cancer Immunology Journal 3 : 8-14 (2010).D. Characiejus et al. Anticancer Research 31:699-703(2011).
